Skip to main content
HUAPONT LIFE SCIENCES CO., LTD. logo

HUAPONT LIFE SCIENCES CO., LTD. — Investor Relations & Filings

Ticker · 002004 ISIN · CNE000001JJ6 LEI · 3003009TGXJC0JJVTJ07 Shenzhen Stock Exchange Manufacturing
Open in API
Filings indexed 2,460 across all filing types
Latest filing 2026-04-22 Audit Report / Informat…
Country CN China
Listing Shenzhen Stock Exchange 002004

About HUAPONT LIFE SCIENCES CO., LTD.

https://www.huapont.com.cn

HUAPONT LIFE SCIENCES CO., LTD. operates as a diversified entity specializing in the research, development, manufacturing, and distribution of pharmaceutical and chemical solutions. The company holds a prominent position in the dermatology sector, providing a comprehensive range of therapeutic products for various skin disorders. Its pharmaceutical operations extend to the production of high-quality active pharmaceutical ingredients (APIs) and finished dosage forms. Beyond human health, the organization maintains a significant footprint in the agrochemical sector, focusing on the development and supply of crop protection products, including herbicides and pesticides. The company also integrates healthcare services into its business model, overseeing the operation of medical facilities and specialized clinics. Its strategic focus centers on technological advancement and the maintenance of a robust supply chain to support its global commercial activities.

Recent filings

Filing Released Lang Actions
内部审计制度（2026年4月）
Audit Report / Information Classification · 95% confidence The document is titled as an "Internal Audit System" for a company, detailing the internal audit policies, responsibilities, procedures, and governance structure. It is a comprehensive internal control and audit framework document, not a financial report, earnings release, or announcement. It does not contain financial statements or results but rather outlines internal audit rules and governance. This fits best under Audit Report / Information (AR), which includes standalone audit reports and applied accounting principles, excluding full annual reports. The document is over 6,000 characters and is substantive, not a brief announcement or certification. Therefore, the classification is AR with high confidence.
2026-04-22 Chinese
委托理财管理制度（2026年4月）
Governance Information Classification · 95% confidence The document is a detailed internal policy titled '委托理财管理制度' (Entrusted Financial Management System) for 华邦生命健康股份有限公司, outlining principles, approval procedures, risk control, accounting, and disclosure requirements related to the company's entrusted financial management activities. It references regulatory frameworks such as the Securities Law of China and Shenzhen Stock Exchange listing rules, but it is not a financial report, earnings release, or announcement. It is a governance or management internal control document focused on financial management policies rather than a report or announcement to shareholders or the public. It does not contain financial statements or results, nor is it a certification or announcement of a report. Therefore, the best fitting category is Governance Information (CGR), which covers reports detailing the company's internal rules, board structure, and governance practices.
2026-04-22 Chinese
关于召开2025年年度股东会的通知
AGM Information Classification · 95% confidence The document is a notice about the convening of the 2025 Annual General Meeting (AGM) of Huabang Life Health Co., Ltd. It includes details about the meeting date, voting procedures, proposals to be voted on, and instructions for shareholders. It does not contain the actual annual report or financial statements but rather the announcement and information related to the AGM. The document length is 4115 characters, which is relatively short and consistent with an announcement rather than a full report. Therefore, this document fits the category of AGM Information (AGM-R).
2026-04-22 Chinese
董事会关于独立董事独立性情况的专项意见
Governance Information Classification · 95% confidence The document is a special opinion from the board of directors regarding the independence of independent directors, including detailed self-assessment reports for the year 2025 by two independent directors. It references regulatory requirements for independent directors and confirms their compliance with independence criteria. The content is focused on governance and compliance related to board members' independence rather than financial results, capital changes, or shareholder votes. It is not an annual report, earnings release, or any financial statement. It is also not a proxy solicitation or voting result announcement. The document fits best under Governance Information (CGR) as it details the company's internal governance practices concerning independent directors' independence.
2026-04-22 Chinese
2025年年度审计报告
Audit Report / Information Classification · 95% confidence The document is titled as the "2025年度审计报告" (2025 Annual Audit Report) for 华邦生命健康股份有限公司, issued by 四川华信(集团)会计师事务所, a CPA firm. It contains detailed audit opinions, audit basis, key audit matters such as goodwill impairment and revenue recognition, management and governance responsibilities, and extensive financial statement data including balance sheets, income statements, cash flow statements, and notes. The document is about 15,000 characters long, indicating it is a full report rather than a brief announcement. The content is consistent with a standalone audit report focusing on the audit of the company's financial statements for the fiscal year 2025. It is not an annual report (10-K) because it lacks management discussion and analysis or other sections typical of an annual report. It is not a certification or attestation letter, nor a regulatory announcement. Therefore, the document fits the category of an Audit Report / Information (AR).
2026-04-22 Chinese
关于调整公司组织架构的公告
Board/Management Information Classification · 95% confidence The document is an announcement from Huabang Life Health Co., Ltd. regarding adjustments to the company's organizational structure, approved by the board of directors. It includes details about the restructuring of departments and governance improvements. There is no financial data, no mention of annual or quarterly reports, no voting results, and no mention of legal proceedings or capital changes. The content focuses on management and board-level organizational changes, which fits the category of Board/Management Information (MANG). The document length is short and it is a direct announcement, not a report or presentation.
2026-04-22 Chinese

Browse filings by year

23 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.